Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys ...

Purdue Pharma and the Sackler family have agreed to pay over $7 billion for their role in the opioid crisis. ICE arrests more ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family, who ...

Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of ...

Several states have announced an agreement in principle to settle lawsuits across the country over opioid harms and abate the ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

The pharmaceutical company introduced OxyContin, a brand name of oxycodone ... whose office helped negotiate the settlement agreement. "The Sackler family relentlessly pursued profit at the ...

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement<a class="excerpt-read-more" href=" More ...

Purdue Pharma's earlier settlement plan included a $6 billion contribution from the Sacklers in exchange for immunity from all civil opioid claims.